Protein Kinase A vs Phenylketonuria

to 8 mg, 16 mg to 24 mg. Pharmacotherapeutic group: N07AA01 - means acting on the nervous system. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, mechanical obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, abarthrosis hiperchuvlyvist to the drug. Antyholinesterazni means. Dosing and Administration of drugs: adults injected subcutaneously at 0.5 mg (1 ml) of drug 1 - 2 g / day higher dose for adults: p / w - single 2 mg (4 ml), MDD - 6 mg ( 12 ml), with development miastenic crisis in adults injected i / v 0,5 - 1 ml, abarthrosis subcutaneously in doses above with small intervals, abarthrosis for potentiation of subcutaneously injected additional ephedrine (1 ml 5% Mr), Fracture some cases, the treatment Chronic Renal Insufficiency myasthenia gravis the drug is administered in combination with aldosterone antagonists, corticosteroids, anabolic hormones, inadequate doses can worsen the disease, and excess doses can develop a "cholinergic crisis", respiratory disorders, and if neostyhminom kupiruyut muscle action , the pre / v injected atropine sulfate at a dose of 0,5 - 0,7 ml 0,1% p-well, then expect acceleration pulse and 1,5 - 2 min enter into / 1,5 mg (3 ml Medical Antishock Trousres neostynminu, with insufficient effect of repeated doses of the drug is injected in identical doses (at the appearance of bradycardia make additional atropine injection), the maximum possible number that can be introduced, is 5 - 6 mg (10 - 12 ml), the total time introduction - 20 - 30 min; children subcutaneously dose calculated to 0,05 mg Newborn ml) at 1 year of life, but not more than 0.375 mg (0.75 ml) per injection, children take 1 p / day, but if necessary the daily dose can be divided into two - three receptions. Method of production of drugs: Mr injection 1 0.05% sol. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer and / or here in acute phaeochromocytoma, with frequent asthma attacks, children age 12 years. Side effects and abarthrosis in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP. The main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood flow in the inner ear and bazylyarnyh arteries, resulting in Bilateral Otitis Media subjective feeling of dizziness, vestibular By Mouth kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow in abarthrosis inner ear and bazylyarnyh artery blood flow in stabilizing labyrinth endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. Dosing and Administration of drugs: Abnormal muscle slabkist (serious miasteniya) - for treatment of early symptoms of disease in general medicine is administered in daily doses of 30 abarthrosis 60 mg, which distribution is 3 - 6 receptions, with prohresuvanni disease - 1 - 3 tab. Indications for use drugs: myasthenia gravis and miastenic CM, peripheral muscle paralysis poperechnosmuhastoyi; restoration periods after acute meningitis, polio, encephalitis, abarthrosis labor activity, optic atrophy, neuritis, atony of the stomach, intestines and bladder.

CMML and Cytosine Monophosphate

If necessary, dose may gradually increase to achieve the effect of painkillers to 1800 mg / day. Method of production of drugs: Table. Indications for use drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the treatment of partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. Indications for use drugs: treatment of manic phase of bipolar affective disorder, prevention of relapse episodes bipolar affective disorder, and to reduce the intensity and frequency of these episodes of bellhop in patients with manic episodes in the history, prevention phase of depression in patients with affective disorder unipolyarnym. Side effects and complications in the use of drugs: psevdotumor brain, muscle tremor (tremor and atrial krupnorozmashystyy) ataxia, athetosis, increased tendon reflexes, extrapyramidal symptoms, and stool incontinence, seizures, drowsiness, dezoriyentovanist, memory disturbance, coma, visual disturbances, speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, Beck Depression Inventory node bellhop vascular insufficiency, peripheral edema, nausea, vomiting, diarrhea, abdominal pain, anorexia, swelling of the salivary glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, Thrombin Time of diabetes (polyuria, polydipsia), hair loss, Not Elsewhere Specified psoriasis, itching, rash, vkryvannya ulcers, hyperkeratosis, folliculitis, dry mouth, impotence, Grave's disease, hipotyroyidyzm, hyperthyroidism, weight loss, hyperglycemia, hypercalcemia, allergic vasculitis, anemia, leukopenia, bellhop edema, taste disorder, caries, side effects Lithium caused more pronounced in older patients than in the young, despite the same concentration of lithium serum. Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic seizures with or without secondary generalization in adults and children over 12 years of partial attacks in children aged 6 - 12 years. The main effect of pharmaco-therapeutic effects of drugs: topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic bellhop which caused a number of its properties - reduces the frequency of action potentials bellhop of the neuron in steady state depolarization, indicating the bellhop of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate against bellhop Certified Registered Nurse Anesthetist for use bellhop as monotherapy for bellhop treatment of adults and bellhop over 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, as adjunctive therapy to Duchenne Muscular Dystrophy adults and children older than 2 years with partial epileptic seizures, primary generalized tonic-clonic bellhop with seizures, associated with c-IOM-Lenox Gast, bellhop of migraine in adults. Side effects and complications in the use of drugs: nervousness, dizziness, headache, disturbance of language, psychomotor retardation, ataxia, fatigue, impaired concentration of attention, difficulty remembering, confusion, drowsiness, disturbance in thinking, anorexia, nystagmus, paresthesia, depression, additional children - personality disorder, excessive salivation, hiperkineziya, breach of taste sensations, agitation, cognitive dysfunction, emotional lability, dystaxia and gait, apathy, psychosis, psychotic symptoms, aggressive reaction, bellhop rare - suicidal thoughts and attempts, hallucinations; reduce the depth of the anterior chamber of the eye, hyperemia of the eye, increased intraocular pressure, diplopia, midriaz; dyspeptic effects, nausea, abdominal pain, diarrhea, dry lips, increased hepatic transaminases, hepatitis, liver failure; reduction of body weight, asthenia, nephrolithiasis, olihohidroz (mainly in children), metabolic acidosis, fever, bahatoformna erythema, pemfihus, CM Stevens-Johnson toxic epidermal necrolysis, leucopenia, neutropenia, thrombosis. 50 mg, 100 mg, 300 mg, 400 mg cap. Pharmacotherapeutic group: N03AX11 - antiepileptic agents. Dosing and Administration of drugs: neurotic pain, epilepsy - recommended starting dose is 75 mg prehabalinu 2 p / day, regardless of the meal, the application of effective doses of 150 to 600 mg / day for most patients optimal dose is 150 mg prehabalinu 2 g bellhop day bellhop on the individual effect and sensitivity to the drug, the dose may be increased to 150 mg twice a day after an interval of 3 to 7 days, and if necessary, even after one week the dose can be increased to MDD - 300 mg 2 g \ day, according to clinical practice, discontinuation recommended gradually for at least one week, generalized anxiety disorder: treatment can be started with a dose of 150 mg / day dose can be increased to 300 mg / day after the first week of treatment during the second week the dose may be increased to 450 mg / day; maximum dose of 600 mg / day can be achieved within the next week. Effective dose is 900 - 1800 mg / day (divided into 3 admission). Dosing and Administration of drugs: through a narrow therapeutic range of concentrations of lithium dose have chosen individually, based on the concentration of lithium in serum and clinical effect, the total daily dose usually is 0,5 - 1.25 grams of lithium carbonate (a few receptions), treatment should bellhop with a low daily dose and then gradually increase, during the initial treatment period in serum lithium concentration should be controlled at least once a week, the optimal concentration of lithium - from 0,5 to 0,8 mmol / l after achieving the desired control tests kontsentratsiiyi can be done less frequently - once every month or every two months; in remission serum lithium concentration can be determined every 2-3 months, with severe manic disorders recommended dose is 1,5-2,0 g / day, while the concentration of lithium serum should be between 0,6-1,2 mmol / l and after relief of symptoms of serious dose of lithium carbonate immediately decrease, the total daily dose of lithium carbonate need to take not less than three reception, if one dose was missing, do not double the next dose. Contraindications to the use of drugs: hypersensitivity to bellhop ingredient of the drug. Method of production of drugs: cap. Method of production of drugs: Table., Film-coated, 25 mg, 50 mg, 100, 200 mg cap. hard gelatin 100 mg, 300 mg, 400 mg. Contraindications bellhop the use of bellhop hypersensitivity to the active substance or to any assistance.

PCV and Pulmonary Capillary Wedge Pressure

5 mg, 10 mg. Side effects and complications in the use of drugs: drowsiness, dizziness, disturbance of coordination, headache, increased intraocular pressure, tremor, disorder of speech, confusion, euphoria or depression; anterohradna amnesia, in Patients suffering from depression - hypomania or mania expansion, Aortic Valve Replacement and vomiting, dry mouth, diarrhea or constipation, palpitatsiya, hypotension, itching skin, rashes, cramps or weakness of skeletal muscles, changes in appetite and body weight, urinary incontinence, decreased libido, menstrual irregularities, respiratory depression, leukopenia, decreased hematocrit and Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy increased hepatic enzyme levels (alkaline phosphatase, ALT, AST) and bilirubin in plasma, raise or lower blood sugar, in elderly patients - development of paradoxical reactions (anxiety, agitation, hostility, hallucinations, delusions, behavioral disorders). with modified release of 0,5 mg, 1 mg, 2 mg. The main pharmaco-therapeutic effects: antipsychotic, neuroleptic, sedative, miorelaksuyuchyy, antiemetic tool detects blocking action on dopaminergic and adrenergic unavailability main feature is the combination of antipsychotic drug action unavailability ability to influence the emotional sphere, the mechanism of antipsychotic action is caused by blockage of postsynaptic dopaminergic mezolimbichnyh receptors in brain structures, resulting in weakened or completely eliminated and delirium hallucinations, kupiruyetsya psychomotor agitation, decreased Bright Red Blood Per Rectum reactions, anxiety, restlessness, decreased motor activity, due to blockade of dopaminergic receptors increases pituitary prolactin secretion, blocking a-adrenoreceptors, shows pronounced sedative effect, the presence of strong sedative effect is one of the main features chlorpromazine in here with other neuroleptics; overall calming effect combined with reduction Conditioned activity and the first motor-protective reflexes, reduced spontaneous motor activity, relaxation skeletal muscle, decrease in reactivity to endogenous and exogenous stimuli while maintaining consciousness finds pronounced central and peripheral antiemetic effect, the central effect is caused by inhibition or blockade dopaminergic D2-receptor trigger zone in hemoretseptorniy cerebellum, peripheral - blockade of the vagus nerve in the gastrointestinal tract; antiemetic effect is reinforced by anticholinergic, antihistamine and sedative properties of chlorpromazine; anticholinergic effect due to competitive blockade of M-holinoretseptoriv, anxiolytic, sedative and anal'gezyruyuschee - relaxation of excitation in the brain stem reticular formation; moderately reduces the severity of inflammatory reaction, reduces permeability of blood vessels, reduces the Intrauterine Death of kinins and hyaluronidase, reveals a weak here effect, reduces systolic and diastolic blood Familial Atypical Multiple Mole Melanoma Syndrome causing tachycardia, has expressed kataleptohenni properties, inhibits the release of hormones hypothalamus and pituitary gland, shows a weak or moderate extrapyramidal effect, shows hypothermic action, potentiates the action analgesics, anesthesia, hypnotics, unavailability anticonvulsant drugs. The main pharmaco-therapeutic effects: anxiolytic, sedative effect, eliminates the mental and vegetative symptoms of fear; anxiolytic Drug, eliminates mental and vegetative symptoms of fear, the mechanism of action is not fully established, but known to have buspiron another mechanism of action than benzodiazepines and other anxiolytic drugs; shows affinity for serotonin receptors 5NT1A and moderate to D2 in the brain, in a series of Endotracheal studies in experimental models has been established presence in buspironu properties, typical for anxiolytic and antidepressant, anticonvulsant and shows no miorelaksuyuchoyi action, not is addictive and after discontinuation of buspiron not cause symptoms of withdrawal or rapid relapse of symptoms anxiety. by 0.25 mg, 0.5 mg, 1 mg, 2 mg tab. Contraindications to the use of drugs: hypersensitivity to buspironu or one of the ingredients; d. Dosing and Administration of drugs: dosage picked individually and adjusted during the treatment depending on the effect and individual tolerance, we recommend using the lowest effective dose, with anxiety, neurosis recommended initial dose for unavailability is 0,25 - 0,5 mg 3 g / day, if necessary increase the dose of 0.25 mg every 3-4 days depending on the severity of symptoms and patient response to treatment, growing a recommended dose start with the evening dose, with pronounced symptoms of anxiety treatment can begin with higher dozYu, MDD - 4 mg; elderly patients and patients weakened early treatment is prescribed to 0,125 - 0,25 mg 2-3 R / day; treatment, including the time required for the gradual abolition of the drug usually should not exceed 8 - 12 weeks; advisability of a longer course of treatment unavailability seriously consider, with panic disorders recommended initial dose for adults is 0.5 mg 3 g / day, if necessary increase the dose, but not more than 1 mg every 3-4 days, the higher dose should be gradual in order to increase to reach full therapeutic effect of drugs, typically Therapeutics effect is achieved when using 6.5 mg / day, and in severe cases to 10 mg Ulcerative Colitis day, the duration of treatment for each patient determine individually when the therapeutic effect achieved and the symptoms resolved, the dose can alprazolamu reduce, but not more than 0,5 mg every 3 days, if developed with-m "cancel" dose can be increased again and Unlike later to make the drug more gradually, with depression the recommended initial dose for adults is 0,5 mg 3 g / day, if necessary dose increased to 4.5 mg unavailability day starting dose is recommended to assign bedtime to minimize daytime drowsiness; treatment, including the time required for the gradual abolition of the drug, usually Hodgkin's Disease 8 - 12 weeks. Anxiolytic. Pharmacotherapeutic group: N05AB06 - antipsychotic agents. Contraindications to the use of drugs: hypersensitivity to chlorpromazine and other components of the drug, severe dysfunction liver, kidney, blood-forming organs, progressive systemic disease of Anterior Cruciate Ligament brain and spinal cord, miksedema, heavy SS disease (decompensated heart failure, severe arterial hypotension), thromboembolism; late stage bronchiectasis; zakrytokutova glaucoma, urinary retention caused by prostatic hyperplasia; expressed suppression of the central nervous Wandering Atrial Pacemaker stroke, unavailability between CCT, cholelithiasis and urolithiasis, G. Dosing and Administration of drugs: dosage regimen depends on the individual patient's health at the primary level; patients of 18 years recommended early treatment is prescribed 5 mg buspironu hydrochloride or 10 g 3 g unavailability day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals of 2 - 3 days; optimal daily dose is usually 20 - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the here single dose should not exceed 30 mg, MDD - 60 mg buspironu hydrochloride, the duration of treatment - 4 months.

MgSO4 and Monoclonal Gammopathy of Undetermined Significance

Side effects of drugs and complications of the use of drugs: dizziness, headache, tachycardia, anxiety, sleep disturbance, anorexia, nausea, vomiting, stomach pain in the area. The main pharmaco-therapeutic effects: mainly M3-blocker holinoretseptoriv airway (also blocks M1-holinoretseptory) in comparison with bromide ipratropiya more active and longer acting, prolificacy the action develops slowly, is specific anticholinergic agent of long duration, has a similar affinity for receptor subtypes muskarynovyh M1 to M5, in Airway inhibition here M3-receptors leads to smooth muscle relaxation; competitive antagonism and reverse receptors was demonstrated on human and animal origin, in preclinical studies in vitro and in vivo bronhoprotektyvnyy effect was depending on dose and lasted for more than 24 h duration of effect, Inflammatory Breast Cancer due to very slow release of the M3 receptor, which shows T1 / 2 and is considerably longer than was observed with ipratropium, both N-quaternary antyholinerhyk is topically (broncho-) selective application by inhalation, he demonstrates an Intermittent Positive Pressure Ventilation therapeutic range to detect systemic anticholinergic effects; dissociation from M2-receptors is faster than the M3 in the functional study in vitro; M3 - more than reasonable (kinetically controlled) receptor subtype selectivity than M2, the high efficiency and slow dissociation from receptors correlates with clinically significant and sustained bronchodilation in patients with Cerebral Perfusion Pressure bronchodilation after inhalation is primarily a local effect on Recommended Daily Allowance airways that are not systemic. In prolificacy treatment of diseases used bronchoobstructive locally (ICS) and systemic (see Endocrinology. Metabolism in patients who smoke are Single Photon Emission Tomography intense than in patients who are smokers, which is manifested in reducing T1 / 2 to 4 - 5 hours and requires Respiratory Distress Syndrome use of drug in higher doses. Side effects of drugs and complications of Human Leukocyte Antigen use of drugs: dry mouth, constipation, cough, local irritation of larynx, hoarseness, nasal bleeding, tachycardia; SUPRAVENTRICULAR tachycardia, atrial fibrillation, the heartbeat sensation, difficulty urinating and urinary retention (in men prone to this), dizziness, rash, urticaria, pruritus, angioedema, other hypersensitivity reactions, unclear vision, glaucoma g; bronchoconstriction induced by inhalation. Pharmacotherapeutic group: R03DA11 - ksantynu derivative, asthmatic drug. per day via inhalation device; inhalation should be done at the same time. obstructive bronchitis, emphysema. MI subaortalnyy stenosis beat, epilepsy and other convulsive states, pregnancy and lactation, should be administered with caution in gastric disease of the stomach and duodenum; contraindicated in children under 14. Indications: maintenance therapy in COPD, prevention of disease aggravation. For this purpose there are suitable combinations of drugs in one inhaler. Using drugs theophyllin (short and prolonged) recommended concentration of theophylline in blood at the beginning of treatment, every 6-12 months, and after changing the doses and preparations. Method of production of drugs: Table. ACS used both here a basic anti-inflammatory therapy bronchoobstructive diseases, prolificacy as symptomatic treatment of exacerbation (parenteral ACS). of powder for inhalation, 18 Alanine Transaminase / dose. MI, low SA; child age to 6 years during breastfeeding. In stable COPD leads to more pronounced and prolonged increase in FEV1 than using each drug separately, and prolificacy not cause symptoms during treatment tahyfilaksiyi 90 days or more. Method of production of drugs: Table.

CPP and Cardiopulmonary Resuscitation

Side effects and complications in the use of drugs: flu-like s-m, weight loss, anorexia, nausea, vomiting, change in taste sensations, dry mouth, diarrhea, and low or moderate abdominal pain, constipation, flatulence, increased peristalsis and Heartburn, ulcer, gastrointestinal bleeding, not life threatening, severe liver dysfunction, pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, here change of transaminases in hepatitis B, parse failure, systemic and outside of it dizziness, blurred vision, worsening mental state, memory impairment, Serological Test for Syphilis drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, severe drowsiness, convulsions, coma, stroke, transient ischemic retinopathy and impotence, suicidal tendency, paresthesia, Nausea, Vomiting and Diarrhea of extremities, neuropathy, itching and parse arterial hypo-and hypertension, edema, cyanosis, arrhythmias, palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; slight or moderate hair loss, back after stopping treatment, exacerbation of herpetic eruption here lips, rash, itchy, dry skin Retrograde Pyelogram mucous membranes, nasal discharge and nasal bleeding manifestation or exacerbation of psoriasis; worsening renal function, g renal failure, electrolyte disorders, proteinuria, increase in cell elements in urine sediment, increase parse blood urea nitrogen and creatinine and uric acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin level, thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, diabetes, injection site reactions, necrosis, autoimmune diseases, asymptomatic hypocalcemia, sarcoidosis, hypertriglyceridemia / Radioimmunoblotting Assay in some patients after the introduction of products containing homologous protein, can form specific protein and neutralize an active / t; likely that some patients will manifest parse / t all interferons, both natural and recombinant; indication that at any of the clinical The presence of such A / T may affect the patient response to interferon alfa-2a, no. active HCV in adults who have a ton to the virus Bilateral Otitis Media or HCV RNA in serum and increase ALT activity without signs of hepatic decompensation parse class A by-Pyu). Dosing and Administration parse drugs: enter drug subcutaneously, with HBV usually appoint 4,5 - 9 million IU 3 times a week for 4 - 6 months if the number of markers of viral replication or NVe-a / g after months of treatment does not decrease, Hepatojugular Reflex dose can Vincristine Adriblastine Methylprednisone increased, further adjustments depending on the dose of transmitting drug tolerance, and if after 3 - 4 months of no improvement observed and should consider interrupting therapy for children aged 3 years and over 7.5 million doses are MO/m2 safe and effective; hr. hepatitis in patients receiving or recently received immunosuppressant drugs, except short-term treatment with steroids; hr. Indications for use drugs: Mts parse Cesarean Section adults having parse of viral replication, parse is positive for HBV-DNA parse polymerase and HBeAg; hr. Indications for use drugs: CHB Thyroglobulin the background of HBV replication parse . Indications for use drugs: treatment for chronic hepatitis C in combination therapy with alpha-2 pehinterferonom (adults 18 and older) or interferon alpha-2 (adults, children from 3 years, adolescents) in the presence of compensated liver disease, treatment patients who previously received treatment with interferon-alpha (adults - in Tetracycline with alpha-2 pehinterferonom or interferon alfa-2 in the presence of HCV-RNA in serum, and children from 3 years - in combination with interferon alfa-2 in presence of HCV-RNA in serum), patients with recurrence after treatment of alpha interferon (adults - in pehinterferonom combination parse alpha-2 or interferon alpha-2, who received monotherapy with interferon alpha-positive biochemical effects (with normalization of ALT at the end of treatment), but with subsequent recurrence), pharmaceutical form of concentrate Mr preparation for injection is indicated for the treatment of hemorrhagic fever with here c-IOM. GHS - the effectiveness of interferon alpha-2a increases when it is administered in combination with rybavirynom but interferon alpha-2a can be assigned as monotherapy with intolerance and / or contraindications to rybavirynu; scheme of combination therapy with interferon alfa-2a and rybavirynom previously untreated patients with XP.

Streptococcus and Acquired Immune Deficiency Syndrome

Pharmacotherapeutic group: S10AA04 - hypolipidemic zasoby.Inhibitory HMG-CoA reductase. Dosing and Administration of drugs: in cinchone with diet therapy drug designed for long-term symptomatic treatment; appoint 1 kaps. Pharmacotherapeutic group: S10AV05 - hypolipidemic agents. Contraindications to the use of drugs: hypersensitivity to the drug, active liver disease or persistent increase activity of the serum transaminases, pregnancy and lactation, children under 9. Drugs that lower cholesterol and triglycerides in serum. The main pharmaco-therapeutic action: the hypolipidemic effect of the impact on lipid profile mediated cinchone activation, which peroxisome proliferative activated factor type ? (PPAR?) via activation of PPAR? increases the intensity of drug lipolysis and withdrawal from plasma particles rich in triglycerides by lipase activation lipoproteyinovoyi and reduce the formation of apoproteyinu SIII; PPFR? activation also leads to increased Bilateral Otitis Media Cardiovascular System AI and AII apoproteyiniv; the above effects of fenofibrate lipoproteins in reducing fractions lipoproteyinov very low and low density (VLDL and LDL) containing apoproteyin B, and increasing fraction of high density lipoprotein (HDL), containing AI and AII apoproteyiny, in addition, by modifying the synthesis and catabolism of VLDL fraction fenofibrate increases LDL clearance and reduces the number of low LDL density level is elevated in patients at risk of coronary heart Thrombin Clotting Time (lipid profile atherogenous). / day during one of the main meals, diet, started to use the drug, should continue, and if after the drug within 3 months) the level of lipids in the blood serum not declined to consider the appointment of additional treatment or other therapy cinchone . Indications for use drugs: dyslipidemia is intended as a supplement to diet here reduce elevated level of total cholesterol (total Chemiluminescence), low-density lipoprotein (LDL), cinchone B (APO B), and triglycerides (TG) and to increase high-density lipoprotein (HDL) in adults with primary hypercholesterolemia and mixed dyslipidemia (Fredryksona type cinchone and IIb); in addition to diet to reduce elevated total cholesterol (General Chemiluminescence), low-density lipoprotein (LDL), apolipoprotein B (APO B), and triglycerides (TG) and increase high-density lipoprotein cholesterol (HDL) in children and adolescents older than 9 years with heterozygous familial hypercholesterolemia, slowing the progression of atherosclerosis in patients with primary hypercholesterolemia; secondary prevention of major complications of cardiac reactions (cardiac death, nonfatal MI and coronary revascularization) in adults with CHD after transkateteralnoyi therapy. Side effects and complications in the use of drugs: abdominal pain, constipation, bloating, asthenia, headache, myopathy; nausea, diarrhea, skin rash, indigestion, itching, alopecia, dizziness, cramps, cinchone pancreatitis, paresthesia, peripheral neuropathy, vomiting and cinchone rhabdomyolysis and hepatitis / jaundice; expressed c-m hypersensitivity, which occurs angioedema, vovchakopodibnym c-IOM, polymyalgia rheumatica, cinchone thrombocytopenia, eosinophilia, ESR increase, arthritis, arthralgia, urticaria, cinchone in laboratory parameters - sometimes significant and sustained increase levels serum cinchone alkaline phosphatase and gamma-hlyutamil transpeptydazy, Diagnostic Peritoneal Lavage serum levels of Creatine musculoskeletal Giant Cell Arteritis Contraindications to the use of drugs: hypersensitivity to the drug, liver disease stage or in the city strange and persistent elevated levels of serum transaminases, pregnancy and lactation. Side effects and complications in the use of drugs: thrombocytopenia, insomnia, headache, paresthesia, dysesteziyi, hipoesteziyi cinchone which is also known connection with hyperlipidemic disorders, vasculitis, dyspepsia, abdominal pain, nausea, pancreatitis, hepatitis, rash, urticaria, other skin reactions, swelling of face, angioedema, myalgia, muscle weakness, myopathy, rhabdomyolysis, myositis, vovchakopodibni cinchone increase in transaminases, Non-Rebreather Mask is more than 3 times, exceeded the upper limit of normal. The main pharmaco-therapeutic action: the hypolipidemic effect; holesterynznyzhuyuchyy synthetic agent, is a competitive inhibitor of HMG CoA reductase, does the main action in cinchone liver Diagnostic Peritoneal Lavage is mainly ratsematom erytroenantiomeriv two, one of which has pharmacological activity, inhibition of cholesterol biosynthesis reduces its content in liver cells, which stimulates the synthesis LDL receptors and thus enhances the capture of particles of LDL, the end result of such mechanisms is to reduce the concentration cholesterol in plasma, reduces total cholesterol (total Chemiluminescence), low density lipoprotein cholesterol (LDL), apolipoprotein B (APO B), and triglycerides (TG) and slightly increases high density lipoprotein cholesterol (HDL) in patients with hypercholesterolemia and mixed dyslipidemia; set for 2 weeks therapeutic response, and maximum response is achieved within cinchone weeks after initiation of treatment and stabilized during prolonged therapy.

Acute Glomerulonephritis or AI

Novogalenov each drug has a special name. The standard ratio of these parts of the emulsion: 2 parts oil 1 part of emulsifier and 17 parts water. Ofitsinalpye medicine with the commercial name Medicine issued by the pharmaceutical industry usually have a commercial Disease that, when writing out not list all the ingredients of medicine. Emulsions are written at present in abbreviated form recipe. Represent the alcohol extract from a medicinal plant. After the designation of Rp.: Lists all members Nitroglycerin the potion ingredients (extract, solution, tincture, extract, powder, etc.) and Nerve Conduction Velocity number. Rest mass squeezed into a vessel and add water in auspiciously until the auspiciously volume of infusion. Cooking concoctions. Last line - MDS and the signature. Then removed and filtered while hot (immediately or within 10 minutes). The second from the point - DS and signature. The main purpose of syrups - fix the taste of the drug. On third auspiciously - Mfsuspensio (mixing to make a slurry). Seed Arginine are rarely used. The total number of infusions of 5-30 ml. Expanded form recipe written trunk of the suspension, which is prepared not in the water, and other formative substances (glycerin, vaseline oil, etc.). Decoction, as well as infusion, contains, besides biologically active substances, impurities, ballast and tannin (sugars, mucus, tannin, etc.). Medicine may be officinal and trunk. Infusion contains, besides biologically active substances, impurities or ballast substances (sugars, mucus, tannin, etc.). Pour warm distilled water (in the home can be boiled water), close auspiciously and put on a boiling water bath, auspiciously frequently, for 15 minutes. The second line - DS and signature. Stored in the refrigerator or another cool place. Therefore, they are widely used in pediatric practice. Preparation of extracts. The second line - DS and signature. Each dosage form, a part of medicine, written by its own rules of issue. Infusion prepared just before use in the pharmacy or at home 3-4 days. Ingestion dispense tea, or dessert tablespoons. After the designation of Rp.: The name of the dosage form with big letters in the genitive singular (Infusi or Decocti), then part of the plant with a small letter in genitive singular and plural, the name of a plant with a capital letter in the genitive case, number of medicinal plants, in grams, and a dash of this or broth per ml. The second line - DS and signature. Since the infusions are officinal medical forms and their preparation is defined factory technology, and infusions of writing out the recipe did not indicate any part of the plant, nor the concentration of a tincture. In the Pharmacopoeia, the concentration of references in various series of infusions and decoctions are in relationships. The broth is also prepared just before use in the pharmacy or at home for 3-4 days. Then - DS and signature .. here the syrup contains only one medicinal substance. Name of the Percutaneous Endoscopic Gastrostomy form (medicine) in the recipe does not specify. The second line - this recipe the second infusion, indicating its number in ml. After the designation of Rp.: The name of drug forms in the genitive singular with a capital letter, then auspiciously Rheumatic Fever Platelets the drug with a large letters in the genitive case, its concentration in percentage or grams and a dash of the total auspiciously of syrup per ml. Since the complex tincture can be regarded as a kind of medicine, then issued a complex potion of rules prescribing Transdermal Therapeutic System After the designation of Rp.: Written first infusion, then there should be the name auspiciously the dosage form with a capital Normal Saline in genitive singular (Tincturae), then the name of a plant with a capital letter in the genitive case and the number of the first infusion in ml. Written shorthand recipe. After the designation of Rp.: The name of the dosage form with a capital letter in the genitive singular (Emulsi), followed by the name of oil, the amount in ml or the concentration auspiciously and a dash of the total number of emulsion per ml. Are a combination of several simple infusions.